Cargando…

Single dose dexamethasone prophylaxis of postembolisation syndrome after chemoembolisation in hepatocellular carcinoma patient: A randomised, double-blind, placebo-controlled study

BACKGROUND: Even in the immuno-oncology era, transcatheter arterial chemoembolisation (TACE) is the most effective way to treat intermediate stage hepatocellular carcinoma (HCC). Postembolisation syndrome (PES) is the most common side effect from TACE and there is still no standard prevention guidel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sainamthip, Panot, Kongphanich, Chutcharn, Prasongsook, Naiyarat, Chirapongsathorn, Sakkarin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Clinical Trials Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567509/ https://www.ncbi.nlm.nih.gov/pubmed/34786388 http://dx.doi.org/10.12998/wjcc.v9.i30.9059

Ejemplares similares

The Effect of Intravenous Mannitol Combined With Normal Saline in Preventing Cisplatin-Induced Nephrotoxicity: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Sainamthip, Panot, et al.
Publicado: (2022)

Efficacy of Curcumin on Treating Cancer Anorexia-Cachexia Syndrome in Locally or Advanced Head and Neck Cancer: A Double-Blind, Placebo-Controlled Randomised Phase IIa Trial (CurChexia)
por: Thambamroong, Tawasapon, et al.
Publicado: (2022)

Efficacy of dexamethasone in reducing the postembolisation syndrome in men undergoing prostatic artery embolisation for benign prostatic hyperplasia: protocol for a single-centre, randomised, double-blind, placebo-controlled trial—the ‘DEXAPAE’ study
por: Svarc, Petra, et al.
Publicado: (2021)

A Double-Blind, Placebo-Controlled Randomized Phase IIa Study: Evaluating the Effect of Curcumin for Treatment of Cancer Anorexia–Cachexia Syndrome in Solid Cancer Patients
por: Chaiworramukkul, Aornchuma, et al.
Publicado: (2022)

Is Chemoembolisation of Value in Inoperable Primary Hepatocellular Carcinoma
por: Raoul, Jean-Luc
Publicado: (1998)

Hepatitis C prevalence among men who have sex with men attending a gay bathhouse
por: Chirapongsathorn, Sakkarin
Publicado: (2022)

Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
por: Golfieri, R, et al.
Publicado: (2014)

Antibiotic prophylaxis in acute cholecystectomy revisited: results of a double-blind randomised controlled trial
por: Jaafar, Gona, et al.
Publicado: (2020)

The effect of BI 409306 on heart rate in healthy volunteers: a randomised, double-blind, placebo-controlled, crossover study
por: Müller, Fabian, et al.
Publicado: (2022)

Efficacy of perineural dexamethasone with ropivacaine in thoracic paravertebral block for postoperative analgesia in elective thoracotomy: a randomized, double-blind, placebo-controlled trial
por: Mao, Yu, et al.
Publicado: (2018)

Hybrid Modelling of Transarterial Chemoembolisation Therapies (TACE) for Hepatocellular Carcinoma (HCC)
por: Perfahl, H., et al.
Publicado: (2020)

Antibiotic prophylaxis in breast cancer surgery (PAUS trial): randomised clinical double-blind parallel-group multicentre superiority trial
por: Stallard, Sheila, et al.
Publicado: (2022)

A Pilot Study of Using Smartphone Application vs. Routine Follow-Up for Patient Care in Advanced Non-Small Cell Lung Cancer During the COVID-19 Pandemic Era
por: Prasongsook, Naiyarat, et al.
Publicado: (2022)

Serum cystatin C as a predictor of 90‐day mortality among patients admitted with complications of cirrhosis
por: Suksamai, Anuchit, et al.
Publicado: (2021)

Development and validation of prognostic model to predict mortality among cirrhotic patients with acute variceal bleeding: A retrospective study
por: Chirapongsathorn, Sakkarin, et al.
Publicado: (2021)

Effects of Animal Venoms and Toxins on Hallmarks of Cancer
por: Chaisakul, Janeyuth, et al.
Publicado: (2016)

Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
por: Goadsby, Peter J, et al.
Publicado: (2019)

The therapeutic efficacy of Bifidobacterium animalis subsp. lactis BB‐12(®) in infant colic: A randomised, double blind, placebo‐controlled trial
por: Nocerino, Rita, et al.
Publicado: (2019)

Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinoma
por: Mähringer-Kunz, Aline, et al.
Publicado: (2018)

Identifying optimal candidates for liver resection or transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma
por: Zhao, Shoujie, et al.
Publicado: (2020)

Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation
por: Mishra, Gauri, et al.
Publicado: (2020)

Safety and efficacy of endoscopic cyanoacrylate injection in the management of gastric varices: A systematic review and meta‐analysis
por: Chirapongsathorn, Sakkarin, et al.
Publicado: (2021)

Adjuvant use of melatonin for pain management in dysmenorrhea — a randomized double-blinded, placebo-controlled trial
por: Söderman, Lisa, et al.
Publicado: (2021)

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
por: Kudo, Masatoshi, et al.
Publicado: (2020)

Bacterial lysate add‐on therapy to reduce exacerbations in severe asthma: A double‐blind placebo‐controlled trial
por: de Boer, Geertje M., et al.
Publicado: (2021)

Nasal administration of a probiotic assemblage in allergic rhinitis: A randomised placebo‐controlled crossover trial
por: Mårtensson, Anders, et al.
Publicado: (2022)

Efficacy of Transarterial Chemoembolisation with or without Antiviral Therapy for Patients with Hepatocellular Carcinoma after Radical Hepatectomy
por: Zhu, Yin, et al.
Publicado: (2018)

Pain management in patients with hepatocellular carcinoma after transcatheter arterial chemoembolisation: A retrospective study
por: Guan, Yan, et al.
Publicado: (2023)

Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo‐Controlled, Double‐Blind Phase 2 Trial
por: Pignolo, Robert J., et al.
Publicado: (2022)

A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma
por: Meyer, T, et al.
Publicado: (2013)

Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double-blind, placebo- and positive-controlled thorough QT study
por: Mendzelevski, Boaz, et al.
Publicado: (2012)

Randomized, Double-blind, Placebo-controlled Phase III Trial of Duloxetine Monotherapy in Japanese Patients With Chronic Low Back Pain
por: Konno, Shinichi, et al.
Publicado: (2016)

Adrenomedullin for biologic‐resistant Crohn's disease: A randomized, double‐blind, placebo‐controlled phase 2a clinical trial
por: Kita, Toshihiro, et al.
Publicado: (2022)

Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction - a double-blind, placebo-controlled, cross-over, multiple n = 1 study
por: Emmanuel, A V, et al.
Publicado: (2012)

Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence
por: Kruis, W., et al.
Publicado: (2017)

The effect of gluten in adolescents and young adults with gastrointestinal symptoms: a blinded randomised cross‐over trial
por: Crawley, Caecilie, et al.
Publicado: (2022)

Hypofractionated Stereotactic Radiotherapy after Transarterial Chemoembolisation Failure in an Unresectable Hepatocellular Carcinoma: A Case Presentation
por: Fiorica, Francesco, et al.
Publicado: (2013)

Adjuvant celecoxib and lanreotide following transarterial chemoembolisation for unresectable hepatocellular carcinoma: a randomized pilot study
por: Tong, Huan, et al.
Publicado: (2017)

Prognostic value of preoperative prealbumin levels in patients with unresectable hepatocellular carcinoma undergoing transcatheter arterial chemoembolisation
por: Lei, Kai, et al.
Publicado: (2023)

Cardiac effects of amiselimod compared with fingolimod and placebo: results of a randomised, parallel‐group, phase I study in healthy subjects
por: Harada, Tomohiko, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b0mhvh313388btjhe1b2fe2nhf